Advertisement

Topics

Latest "OMRON Corporation" News Stories

20:24 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "OMRON Corporation" found in our extensive news archives from over 250 global news sources.

More Information about OMRON Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about OMRON Corporation for you to read. Along with our medical data and news we also list OMRON Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of OMRON Corporation Companies for you to search.

Showing "OMRON Corporation" News Articles 1–25 of 606

Relevant

OMRON gründet die OMRON SINIC X Corporation, um die „Designs für morgen zu finden: OMRONs ...

Das Forschungsunternehmen ist ein strategischer Eckpfeiler, der die Grundlage dafür liefert, was OMRON als die „Designs für morgen" betrachtet. Zu diesem Zweck wurden prominente Fachleute Read more...


Omron Healthcare President CEO, Ranndy Kellogg, Named Chair Of The American Heart Association's ...

LAKE FOREST, Ill., Oct. 23, 2018 /PRNewswire/ -- Omron Healthcare and the American Heart Association (AHA) today announced that Ranndy Kellogg, Omron Healthcare president and Read more...

OMRON to Introduce CK3M-series Programmable Multi Axis Controller That Delivers World-beating ...

KYOTO, Japan, Aug. 3, 2018 /PRNewswire/ -- - Nano-level High-precision Positioning - OMRON Corporation announced the global release in August of its new CK3M-series Programmable Read more...


OMRON to Introduce FHV7-series Smart Camera with World's First Multi-color Light and 12-Mpix ...

KYOTO, Japan, Nov. 5, 2018 /PRNewswire/ -- OMRON Corporation announced the global release in November of its new FHV7-series Smart Camera combined with illumination and Read more...

OMRON to Introduce NX-series Safety Network Controller That is World's First (*1) to Support ...

KYOTO, Japan, Oct. 3, 2018 /PRNewswire/ -- OMRON Corporation, based in Shimogyo-Ku, Kyoto, announced the global release of its new NX-series Safety Network Controller that Read more...

Omron Healthcare Co Ltd Strategic SWOT Analysis Review [Report Updated: 05072018] Prices from USD $125

Omron Healthcare Co Ltd Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your busi...

Orion Corporation: Managers' transactions - EVK-Capital Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 31 MAY 2018 at 18.30 EEST              Orion Corporation: Managers' transactions - EVK-Capital Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their c...

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. ...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated...

Evaluation of the Omron HEM-907 automated blood pressure device: comparison with office and ambulatory blood pressure readings

Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä

ORION CORPORATION         MANAGERS' TRANSACTIONS 8 MAY 2018 at 16.30 EETS Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associ...

The AI edge

On stand B32 at this year s PPMA show, Omron, a leading industrial automation company, will showcase its new solution that adds artificial intelligence (AI) functionality to machinery for real-time control, providing an instant reduction in waste and machine downtime

International Stem Cell Corporation Granted Key Patent in US

CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company a key patent (US9926529B2) on ...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of the Off Grid Grow Lab (“OGGL”). Mr. Vinson has over 35-years experience in managing the marketing efforts for innovative technology in emerging markets. He began sales efforts in the technology s...

Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business

Sunnyvale, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that management and staff are commemorating its 25-year business anniversary. On November 1, 1993, with two telephones and seed capital borrowed from their parents, entrepreneurs Rene Schena and Todd Martinsky founded industrial and specialty chemicals manu...

Geron Corporation Reports First Quarter 2018 Financial Results

MENLO PARK, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2018. First Quarter 2018 Results For the first quarter of 2018, the company reported operating revenues of $318,000 and operating expenses of $7.8 million compared to $537,000 and $8.0 million, respectively, for the comparable 2017 period...

International Stem Cell Corporation Developed 3D Liver Structures

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that ISCO’s Research and Development team has developed novel methods that efficiently generate...

Vericel Corporation Prices $65 Million Public Offering of Common Stock

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock, at a price to the public of $13.00 per share.  The gross proceeds to Vericel from this offerin...

International Stem Cell Corporation to Launch Advanced Joint Supplement

CARLSBAD, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company plans to launch its advanced joint supplement, designed to potentially reduce jo...

ContraFect Corporation Announces Proposed Public Offering of Common Stock

YONKERS, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that it has commenced an underwritten public offering of its common stock. All shares in the offering are to be sold by ContraFect. Th...

ContraFect Corporation Prices $10 Million Public Offering of Common Stock

YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced the pricing of its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $2.00 per share....

Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam

Regalia®, Grandevo® and Majestene® to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins DAVIS, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, to...

Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation

External manufacturing agreement reached to enable production of clinical trial materials for SB204 and the acne indication, with the potential to include additional product candidatesExtension of capacity complements existing internal operations, proprietary technological knowledge, intellectual property strategy and production skillsAgreement aligns with and supports global business development...

Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services

Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program.  Arrayit’s new CLIA license, issued in conjunction with the Department of Health an...

Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists

Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP).  Arrayit received a perfect score in highly quantitative measurements of immunoglobulin E (IgE), the antibodies in the human ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks